Examkin

Question

Difficulty: MediumDiagnostic Workup and Test Sequencing

An adult patient is referred to an endocrinology clinic due to progressive changes in facial features, widening of the hands, and hyperhidrosis developing over the past three years. The primary care provider obtained initial screening laboratory studies, which revealed a serum insulin-like growth factor-1 (IGF-1) concentration substantially above the upper limit of normal for the patient's age and sex. Renal and hepatic function panels are unremarkable. Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

  1. Measurement of serum growth hormone following an oral glucose loadAnswer
  2. B
    Magnetic resonance imaging of the sella turcica
  3. C
    Measurement of a random serum growth hormone level
  4. D
    Automated perimetry to assess visual fields
  5. E
    Assessment of an anterior pituitary hormone panel

Answer

Measurement of serum growth hormone following an oral glucose load
The correct next step is to perform an oral glucose tolerance test (OGTT) with concurrent measurement of serum growth hormone (GH) levels. The diagnostic workup for suspected acromegaly follows a strict, step-wise sequence to ensure diagnostic accuracy. Because GH is secreted in a highly pulsatile manner, a single random GH measurement is clinically unhelpful. Instead, serum insulin-like growth factor-1 (IGF-1) is used as the initial screening test because it provides an integrated measure of GH secretion over time and has a long half-life. Once an elevated IGF-1 level suggests the diagnosis, it must be biochemically confirmed by demonstrating the loss of normal physiologic feedback. Under normal physiologic conditions, a glucose load robustly suppresses GH secretion. Therefore, the failure of GH to suppress to less than 1 ng/mL following a standard 75g oral glucose load confirms the diagnosis of autonomous GH hypersecretion. Only after this definitive biochemical confirmation is achieved should structural imaging (such as an MRI of the sella turcica) be ordered to localize the source, which is typically a pituitary adenoma.

Step-by-Step Solution

1
Identify the suspected clinical diagnosis based on the patient's presentation.
The patient has classic somatic features of acromegaly, supported by a significantly elevated screening IGF-1 level.
Recognizing the condition and the current stage of the diagnostic algorithm dictates the subsequent workup.
2
Determine the guideline-recommended sequence for confirming this specific condition.
An elevated screening IGF-1 level requires definitive biochemical confirmation of autonomous growth hormone (GH) secretion prior to ordering structural imaging.
Because pituitary incidentalomas are common in the general population, biochemical proof of disease must precede anatomical localization to prevent false-positive diagnostic attributions.
3
Select the appropriate biochemical confirmatory test.
The oral glucose tolerance test (OGTT) with GH measurement is selected.
In healthy individuals, a glucose load suppresses GH secretion. Failure of GH to suppress to normal limits confirms autonomous hypersecretion.

Key Concept

The diagnostic sequencing of acromegaly requires initial screening with serum IGF-1, followed by biochemical confirmation using an oral glucose tolerance test (OGTT) to demonstrate failure of growth hormone suppression, prior to obtaining an MRI of the pituitary gland.
Rate this question

Topics

Diagnostic Workup and Test Sequencing

More questions from this topic